FOMAT

NASH- NCT06215716

A study exploring a possible new treatment for adults living with NASH or MASH and liver fibrosis.

Criteria & Qualifications:

  • Are between 18 and 80 years of age
  • Have been diagnosed with NASH or MASH with liver scarring
  • Have metabolic health conditions such as obesity, high blood pressure, high blood sugar, abnormal cholesterol, or type 2 diabetes

Compensation: Contact Us for more info